Michael Zand – Page 1864

Israel’s BrainStorm Offers Encouraging Phase 2 Data on Stem-Cell Therapy NurOwn to Treat ALS – ALS News Today

2017-04-11 Michael Zand NEWS

New Technique Helps Determine How Stem Cells Differentiate – Technology Networks

Technology NetworksNew Technique Helps Determine How Stem Cells DifferentiateTechnology NetworksMSCs have proven to be important for regenerative medicine and stem cell therapy because they can potentially repair many different types of organ damage, a… Continue reading

2017-04-11 Michael Zand NEWS

Immunotherapy Market Production, Revenue, Price Trend & Forecast Report 2017-2022 – Medgadget (blog)

Green Mountain OutlookImmunotherapy Market Production, Revenue, Price Trend & Forecast Report 2017-2022Medgadget (blog)The Immunotherapy Market 2017 Industry Research Report is a professional and in-depth study. This study covers, Global Immunother… Continue reading

2017-04-11 Michael Zand NEWS

The Most Important Battle in Gene Editing: CRISPR versus TALEN – Labiotech.eu (blog)

The Most Important Battle in Gene Editing: CRISPR versus TALENLabiotech.eu (blog)Despite all the hype, CRISPR is still not in the clinic as a standalone therapy or part of another. So where is it in biotech? CRISPR needs no introduction. Since the gene… Continue reading

2017-04-11 Michael Zand NEWS

Mundipharma partners with Kolon Life Science to market cell-medicated gene therapy – BSA bureau (press release)

BSA bureau (press release)Mundipharma partners with Kolon Life Science to market cell-medicated gene therapyBSA bureau (press release)Singapore: Mundipharma has announced a strategic partnership with Kolon Life Science to market Invossa, cell-medicated… Continue reading

2017-04-11 Michael Zand NEWS

Mundipharma partners with Kolon Life Science to market cell-medicated gene therapy – BSA bureau (press release)

2017-04-11 Michael Zand NEWS

Researchers use graphene, electricity to change stem cells for nerve regrowth – ScienceBlog.com (blog)

ScienceBlog.com (blog)Researchers use graphene, electricity to change stem cells for nerve regrowthScienceBlog.com (blog)So researchers have been taking readily available and noncontroversial mesenchymal stem cells (also called bone marrow stromal stem… Continue reading

2017-04-11 Michael Zand NEWS

CRISPR mines bacterial genome for hidden pharmaceutical treasure – ScienceBlog.com (blog)

ScienceBlog.com (blog)CRISPR mines bacterial genome for hidden pharmaceutical treasureScienceBlog.com (blog)In the fight against disease, many weapons in the medicinal arsenal have been plundered from bacteria themselves. Using CRISPR-Cas9 gene-editing… Continue reading

2017-04-11 Michael Zand NEWS

1
…
1,862
1,863
1,864
1,865
1,866
…
3,823

ALS News Today

Israel’s BrainStorm Offers Encouraging Phase 2 Data on Stem–Cell Therapy NurOwn to Treat ALS
ALS News Today
Israel’s BrainStorm Cell Therapeutics has announced positive top-line Phase 2 data on NurOwn, a customized stem–cell therapy technology to treat amyotrophic lateral sclerosis (ALS). BrainStorm has been developing and commercializing NurOwn in …

Login

Cart

All posts by: Michael Zand

Israel’s BrainStorm Offers Encouraging Phase 2 Data on Stem-Cell Therapy NurOwn to Treat ALS – ALS News Today

New Technique Helps Determine How Stem Cells Differentiate – Technology Networks

Immunotherapy Market Production, Revenue, Price Trend & Forecast Report 2017-2022 – Medgadget (blog)

The Most Important Battle in Gene Editing: CRISPR versus TALEN – Labiotech.eu (blog)

Mundipharma partners with Kolon Life Science to market cell-medicated gene therapy – BSA bureau (press release)

Mundipharma partners with Kolon Life Science to market cell-medicated gene therapy – BSA bureau (press release)

Researchers use graphene, electricity to change stem cells for nerve regrowth – ScienceBlog.com (blog)

CRISPR mines bacterial genome for hidden pharmaceutical treasure – ScienceBlog.com (blog)